Isoquinoline compound melanocortin receptor ligands and methods of using same
US6127381A · kind A · utility
33Cited by
9References
69Claims
0Family size
Inventors
Key dates
| Filing date | Apr 28, 1999 |
| Grant date | Oct 3, 2000 |
| Priority date | — |
| Expiry date | Apr 28, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC40B40/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention relates to melanocortin receptor ligands and methods of using the ligands to alter or regulate the activity of a melanocortin receptor. The invention further relates to tetrahydroisoquinoline aromatic amines that function as melanocortin receptor ligands and as agents for controlling cytokine-regulated physiologic processes and pathologies, and combinatorial libraries thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.